Your browser doesn't support javascript.
loading
Are providers prepared for genomic medicine: interpretation of Direct-to-Consumer genetic testing (DTC-GT) results and genetic self-efficacy by medical professionals.
McGrath, Scott P; Walton, Nephi; Williams, Marc S; Kim, Katherine K; Bastola, Kiran.
Affiliation
  • McGrath SP; School of Interdisciplinary Informatics, University of Nebraska at Omaha, 1110 S 67TH St., Omaha, 68182, NE, USA. smcgrath@unomaha.edu.
  • Walton N; Genomic Medicine Institute, Geisinger, 100 N. Academy Ave., Danville, 17822, PA, USA.
  • Williams MS; Genomic Medicine Institute, Geisinger, 100 N. Academy Ave., Danville, 17822, PA, USA.
  • Kim KK; Betty Irene Moore School of Nursing, UC Davis, 2570 48th St., Sacramento, 95817, CA, USA.
  • Bastola K; School of Interdisciplinary Informatics, University of Nebraska at Omaha, 1110 S 67TH St., Omaha, 68182, NE, USA.
BMC Health Serv Res ; 19(1): 844, 2019 Nov 25.
Article in En | MEDLINE | ID: mdl-31760949
ABSTRACT

BACKGROUND:

Precision medicine is set to deliver a rich new data set of genomic information. However, the number of certified specialists in the United States is small, with only 4244 genetic counselors and 1302 clinical geneticists. We conducted a national survey of 264 medical professionals to evaluate how they interpret genetic test results, determine their confidence and self-efficacy of interpreting genetic test results with patients, and capture their opinions and experiences with direct-to-consumer genetic tests (DTC-GT).

METHODS:

Participants were grouped into two categories, genetic specialists (genetic counselors and clinical geneticists) and medical providers (primary care, internists, physicians assistants, advanced nurse practitioners, etc.). The survey (full instrument can be found in the Additional file 1) presented three genetic test report scenarios for

interpretation:

a genetic risk for diabetes, genomic sequencing for symptoms report implicating a potential HMN7B distal hereditary motor neuropathy VIIB diagnosis, and a statin-induced myopathy risk. Participants were also asked about their opinions on DTC-GT results and rank their own perceived level of preparedness to review genetic test results with patients.

RESULTS:

The rates of correctly interpreting results were relatively high (74.4% for the providers compared to the specialist's 83.4%) and age, prior genetic test consultation experience, and level of trust assigned to the reports were associated with higher correct interpretation rates. The self-selected efficacy and the level of preparedness to consult on a patient's genetic results were higher for the specialists than the provider group.

CONCLUSION:

Specialists remain the best group to assist patients with DTC-GT, however, primary care providers may still provide accurate interpretation of test results when specialists are unavailable.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Competence / Health Personnel / Self Efficacy / Direct-To-Consumer Screening and Testing / Genetics Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: BMC Health Serv Res Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2019 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Competence / Health Personnel / Self Efficacy / Direct-To-Consumer Screening and Testing / Genetics Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: BMC Health Serv Res Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2019 Type: Article Affiliation country: United States